Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk (Q60924346)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

C P Palazón

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Alfón

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Gaffney

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Berrozpe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T Royo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

333-345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Gemfibrozil enhances platelet activity in patients with combined hyperlipoproteinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

A pilot study of the effect of Gemfibrozil on some haematological parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

The isolation and properties of pig plasma lipoproteins and partial characterisation of their apoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Generation and partial characterization of five monoclonal antibodies with high affinities for fibrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Apparent reduced absorption of gemfibrozil when given with colestipol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Gemfibrozil absorption and elimination in kidney and liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900236-0

10.1016/S0021-9150(97)00236-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543105%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference